Revance Therapeutic (RVNC) PT Raised to $28 at H.C. Wainwright
Tweet Send to a Friend
H.C. Wainwright analyst Douglas Tsao raised the price target on Revance Therapeutic (NASDAQ: RVNC) to $28.00 (from $23.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
